Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

(NASDAQ:SNY) Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

What impact could the launch of amlitelimab have on Sanofi’s broader dermatology pipeline and long‑term market positioning? What is the expected timeline for FDA approval of amlitelimab and how might it compete with existing biologics for atopic dermatitis like dupixent? How will the COAST 1 results affect Sanofi’s upcoming earnings guidance and short‑term stock performance?
Symbol: SNY
Clinical trials
4 days ago
Read more globenewswire

Spring Valley Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering

(NASDAQ:SVACU) DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, ...

What is the anticipated timeline and target criteria for the SPAC’s business combination, and which industries or assets are being considered? How does the $10.00 per unit pricing compare to recent SPAC IPO benchmarks and does it suggest a valuation premium for the target business? What is the potential dilution from the one‑third warrants attached to each unit and how might it impact future earnings per share?
Symbol: SVACU
Ipo
4 days ago
Read more globenewswire

Bruker Announces Pricing of Public Offering of $600 Million of 6.375% Mandatory Convertible Preferred Stock

(NASDAQ:BRKR) BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (“Bruker”) (Nasdaq: BRKR) today announced the pricing of its previously announced public offering of $600.0 milli...

How does the pricing and size of this preferred offering compare to recent capital raises by peers in the scientific instruments sector? What are the terms and timeline for conversion, and how might they influence the company's leverage and credit metrics? How will the mandatory conversion feature and 6.375% coupon affect Bruker's cost of capital and equity dilution?
Symbol: BRKR
Financing
4 days ago
Read more businesswire

Strathcona Resources Ltd. Provides Update on Form of $2.1 Billion Special Distribution

(NYSE:STR) CALGARY, AB, Sept. 3, 2025 /PRNewswire/ - Strathcona Resources Ltd. ("Strathcona") announced today the anticipated form of the previously disclosed $2.142 billion special distribution (t...

Will the announcement of the special distribution lead to a significant price movement or change in trading volume for STR, and how does it compare to similar events in the sector? How will the special distribution affect Strathcona's cash flow, balance sheet strength, and potential future earnings? What is the expected timeline and tax treatment for the $2.1 billion special distribution to shareholders?
Symbol: STR
Dividends
4 days ago
Read more prnewswire

Customers Bancorp, Inc. Announces Pricing of Voting Common Stock Offering

(NYSE:CUBI) WEST READING, Pa.--(BUSINESS WIRE)---- $CUBI #Banking--Customers Bancorp, Inc. (NYSE: CUBI) (“Customers” or the “Company”), a holding company that operates through its wholly owned bank...

How does the pricing at $68.50 per share compare to recent trading levels and to similar bank equity offerings, and what is the likely near‑term impact on the stock price and liquidity? What is the intended use of proceeds from the offering and how will it support the bank's growth or capital adequacy? How will the $150 million equity raise and resulting dilution affect CUBI's earnings per share and valuation metrics?
Symbol: CUBI
Equity offering
4 days ago
Read more businesswire

Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes

(NASDAQ:MESO) NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it h...

How will the potential repayment of secured debt improve MESO's balance sheet and credit profile, and what impact might this have on the company's financing flexibility and valuation? What are the terms (interest rate, conversion price, maturity) of the convertible notes and how do they compare to the company's existing debt structure? How will the issuance of up to $50 million in convertible notes affect MESO's dilution and share price dynamics?
Symbol: MESO
Financing
4 days ago
Read more globenewswire

Acceleware Ltd. Announces Closing of Second Tranche of Non-Brokered Private Placement

(NYSE:AXE) CALGARY, Alberta, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Acceleware¼ Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-...

How does this non‑brokered private placement compare to recent financing activity of peer companies in the RF power‑to‑heat and critical minerals space? What specific projects or operational milestones will the proceeds be allocated to, and what is the expected timeline for ROI? How will the additional $209,000 raise and total $1M financing dilute existing shareholders and affect the current share price?
Symbol: AXE
Financing
4 days ago
Read more globenewswire

LNTH Investors Have Opportunity to Join Lantheus Holdings, Inc. Fraud Investigation with the Schall Law Firm

(NASDAQ:LNTH) LOS ANGELES, Sept. 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lant...

Could the allegations trigger additional regulatory action or penalties that might impact the company’s financial performance? What is the expected timeline for the investigation and any potential settlement or judgment? How will the lawsuit outcome affect LNTH's near‑term valuation?
Symbol: LNTH
Lawsuits
4 days ago
Read more prnewswire